Literature DB >> 6885161

Precipitating cross-reactions among pneumococcal types.

M Heidelberger.   

Abstract

Data accumulated over many years are brought together on cross-reactions of 46 among the more than 80 pneumococcal serological types, with the idea of correlating cross-reactions with the structures of the relevant type-specific capsular polysaccharides, insofar as these have been determined. The precipitin reaction was carried out with the polysaccharides and antibodies raised in horses, rabbits, and a mule. Quantitative values (micrograms of antibody nitrogen per milliliter of antiserum at 0 to 1 degree C) are given in many instances and discussed, together with arbitrary qualitative data, in terms of the known structures of the polysaccharides. Some precise relationships are uncovered, and an attempt is made to determine why some of the cross-reactions are reciprocal and why others are only unilateral.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6885161      PMCID: PMC264631          DOI: 10.1128/iai.41.3.1234-1244.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  THE SPECIFIC POLYSACCHARIDE OF TYPE 18A PNEUMOCOCCU.

Authors:  M HEIDELBERGER; S ESTRADA-PARRA; R BROWN
Journal:  Biochemistry       Date:  1964-10       Impact factor: 3.162

2.  Preparation and Analysis of Diagnostic Antipneumococcus Serum.

Authors:  H Welch; E K Borman; F L Mickle
Journal:  Am J Public Health Nations Health       Date:  1939-01

3.  The type-specific substance from Pneumococcus type 11A(43).

Authors:  D A Kennedy; J G Buchanan; J Baddiley
Journal:  Biochem J       Date:  1969-10       Impact factor: 3.857

4.  The specific capsular polysaccharide of Pneumococcus type IV.

Authors:  J D Higginbotham; M Heidelberger
Journal:  Carbohydr Res       Date:  1972-07       Impact factor: 2.104

5.  Immunochemical relationships of certain capsular polysaccharides of Klebsiella, pneumococci and Rhizobia.

Authors:  M Heidelberger; W F Dudman; W Nimmich
Journal:  J Immunol       Date:  1970-06       Impact factor: 5.422

6.  Degradation of a pneumococcal type-specific polysaccharide with exposure of group-specificity.

Authors:  J D Higginbotham; M Heidelberger; E C Gotschlich
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

7.  The specific substance from Pneumococcus type 34 (41). The phosphodiester linkages.

Authors:  G J Chittenden; W K Roberts; J G Buchanan; J Baddiley
Journal:  Biochem J       Date:  1968-10       Impact factor: 3.857

8.  The specific capsular polysaccharide of Streptococcus pneumoniae type 9V.

Authors:  M B Perry; V Daoust; D J Carlo
Journal:  Can J Biochem       Date:  1981-07

9.  CROSS-REACTIONS OF PNEUMOCOCCAL TYPES. QUANTITATIVE STUDIES WITH THE CAPSULAR POLYSACCHARIDES.

Authors:  M HEIDELBERGER; J M TYLER
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

10.  Some biological properties of Pneumococcus type 37 and the chemistry of its capsular polysaccharide.

Authors:  J C Knecht; G Schiffman; R Austrian
Journal:  J Exp Med       Date:  1970-09-01       Impact factor: 14.307

View more
  13 in total

1.  Characterization of the type 8 capsular gene cluster of Streptococcus pneumoniae.

Authors:  R Muñoz; M Mollerach; R López; E García
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

Review 2.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

3.  Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?

Authors:  A Soininen; G van den Dobbelsteen; L Oomen; H Käyhty
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

4.  Genetic relatedness of the Streptococcus pneumoniae capsular biosynthetic loci.

Authors:  Angeliki Mavroidi; David M Aanensen; Daniel Godoy; Ian C Skovsted; Margit S Kaltoft; Peter R Reeves; Stephen D Bentley; Brian G Spratt
Journal:  J Bacteriol       Date:  2007-08-31       Impact factor: 3.490

5.  Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease.

Authors:  Chiara Azzari; Maria Moriondo; Giuseppe Indolfi; Martina Cortimiglia; Clementina Canessa; Laura Becciolini; Francesca Lippi; Maurizio de Martino; Massimo Resti
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

6.  Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.

Authors:  E Alonso de Velasco; A F Verheul; A M van Steijn; H A Dekker; R G Feldman; I M Fernández; J P Kamerling; J F Vliegenthart; J Verhoef; H Snippe
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

7.  Nucleotide sequence analysis of CDR3 elements of a panel of anti-peptide monoclonal antibodies recognizing parathyroid hormone-related protein.

Authors:  R Rapley; P S Flora; D J Walsh; M R Walker
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

8.  Two murine natural polyreactive autoantibodies are encoded by nonmutated germ-line genes.

Authors:  R Baccala; T V Quang; M Gilbert; T Ternynck; S Avrameas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

9.  A human monoclonal macroglobulin with specificity for alpha(2----8)-linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA.

Authors:  E A Kabat; K G Nickerson; J Liao; L Grossbard; E F Osserman; E Glickman; L Chess; J B Robbins; R Schneerson; Y H Yang
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

10.  Crossreactions of Escherichia coli K and O polysaccharides in antipneumococcal and anti-Salmonella sera.

Authors:  M Heidelberger; K Jann; B Jann
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.